Find investors
← Back to all investors
Dan Burkhart
ResearchedAngel Investors

Dan Burkhart

Associate

Angel InvestorsSeed Round
Pitch Dan

Get their honest, personalized take on your startup.

Sign in to pitch Dan

At a glance

Full Name
Daniel ("Dan") Burkhart
Title
Associate
Firm
Flexpoint Ford, LLC
Firm Type
Private Equity (middle-market; control and growth-equity investing) — *note: the source CRM record labeled him "Angel Investor / Seed," which does not match Flexpoint Ford's actual strategy (see Background).*
Investment Stage
Control buyouts and growth-equity investments in established, revenue-generating middle-market companies (not seed/angel)
Check Size
~$50M–$500M per investment (firm-level equity check range)
Target Company Profile
Established middle-market operating companies in financial, business, and healthcare services
Sector Focus
Financial services / insurance / fintech, business services, and healthcare services
Geographic Focus
Primarily North America
Location
Chicago, Illinois (firm headquarters; consistent with the 312 phone area code)

Background

Dan Burkhart is listed as an Associate at Flexpoint Ford, LLC, a Chicago-based private equity firm. On the investment team, an Associate typically supports deal sourcing, financial modeling, diligence, and portfolio-company monitoring under the direction of Vice Presidents, Principals, and Managing Directors. His firm email ([hidden]) and a 312 (Chicago) phone number are consistent with a role based out of the firm's headquarters.

Flexpoint Ford was founded in 2005 and specializes in privately negotiated control and growth investments, concentrating on the financial services and healthcare industries as well as the broader business-services ecosystem. The firm has raised more than $7 billion in capital (roughly $7.8B in regulatory assets under management), most recently closing Flexpoint Fund IV and an Overage Fund with a combined $2.0 billion of committed capital, and has invested in 50+ companies since inception. It maintains offices in Chicago, New York, and Miami.

Because Flexpoint Ford invests $50M–$500M into established middle-market businesses, the "Angel Investors / Seed Round" classification in the stub data appears to be an inaccurate CRM tag. Dan's actual work sits squarely in institutional private equity, not early-stage angel investing.

A note on verification: Dan Burkhart does not currently appear on Flexpoint Ford's public "Our Team" roster or in the firm's 2024–2025 promotion announcements, which suggests he may have moved on from the firm since this record was created. His individual bio page (flexpointford.com/dan_burkhart/) still resolves and carries his headshot, but the firm does not publish detailed education or prior-employer history for him, so those specifics are not asserted here to avoid conflating him with other people who share the name.

Investment Thesis & Focus

  • Stage: Institutional private equity — control buyouts and growth-equity stakes in mature, cash-generating companies; not a seed/angel or venture check-writer.
  • Check size: Firm targets roughly $50M–$500M of equity per transaction.
  • Sectors (firm mandate): Financial services (including insurance, wealth/asset management, and fintech), business services, and healthcare services. Flexpoint describes itself as bringing "deep experience across financial, business, and healthcare services, supporting companies with a collaborative, targeted investment approach across the broader services ecosystem."
  • What earns a "yes": Established platforms with recurring revenue and clear consolidation or expansion potential, where the firm can partner with management on organic growth and add-on M&A (its stated "expansion and growth strategy").
  • Structure: Privately negotiated majority/control and strategic growth investments, often serving as a platform for buy-and-build roll-ups.

Notable Investments

  • Accuserve Solutions — Independent managed-repair services platform for the insurance industry; Flexpoint agreed to a majority investment (announced March 2024).
  • Apollo Care — Developer of patient-access and analytics solutions for pharmaceutical brands; received a Flexpoint growth-equity investment (December 2024).
  • Parkview Health Services / ArtesRx — Strategic growth investment via Flexpoint affiliate ArtesRx (closed June 2023, healthcare/pharmacy services).
  • Clearstead — Cleveland-based RIA/wealth-management firm that received a Flexpoint majority equity investment (later added Burkhart & Co.).
  • TOP RX — VAWD-accredited national distributor of generic pharmaceuticals (healthcare distribution).
  • TigerRisk Partners — Reinsurance brokerage; Flexpoint fully exited its position in 2023.
  • Enstar — Insurance run-off specialist; Flexpoint fully exited its position in 2024.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.